指南与共识
ENGLISH ABSTRACT
临床核医学辐射安全专家共识
中华医学会核医学分会《临床核医学辐射安全专家共识》编写委员会
作者及单位信息
·
DOI: 10.3760/cma.j.issn.2095-2848.2017.04.008
Expert consensus on radiation safety in clinical nuclear medicine
Writing Committee of Chinese Society of Nuclear Medicine for the Expert Consensus on Radiation Safety in Clinical Nuclear Medicine
Authors Info & Affiliations
Writing Committee of Chinese Society of Nuclear Medicine for the Expert Consensus on Radiation Safety in Clinical Nuclear Medicine
·
DOI: 10.3760/cma.j.issn.2095-2848.2017.04.008
1916
402
0
0
10
3
PDF下载
APP内阅读
摘要

辐射安全是临床核医学的重要组成部分,也是临床核医学工作中的重要和关键内容之一,日常工作中应用较多且备受关注。但目前国内尚缺乏临床核医学辐射安全指导性文件。为使临床核医学工作开展得更规范,中华医学会核医学分会编写了《临床核医学辐射安全专家共识》(以下简称《共识》)。《共识》编写参照国际机构和中华人民共和国国家标准进行,编写组参阅大量国内外权威指南、规范、教材、专著、文献及相关政策法规,并经核医学、放射医学及辐射防护专家的反复论证。但《共识》仍存在很多不足,望刊出后能得到有益的反馈与指正,以便日后进一步完善。

引用本文

中华医学会核医学分会《临床核医学辐射安全专家共识》编写委员会. 临床核医学辐射安全专家共识[J]. 中华核医学与分子影像杂志,2017,37(4):225-229.

DOI:10.3760/cma.j.issn.2095-2848.2017.04.008

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
本文评分
5 [累计1个]
一、前言
辐射安全是临床核医学的重要组成部分,也是临床核医学工作中的重要和关键内容之一,日常工作中应用较多且备受关注。但目前国内尚缺乏临床核医学辐射安全指导性文件。为使临床核医学工作开展得更规范,中华医学会核医学分会编写了《临床核医学辐射安全专家共识》(以下简称《共识》)。《共识》编写参照国际机构和中华人民共和国国家标准进行,编写组参阅大量国内外权威指南、规范、教材、专著、文献及相关政策法规,并经核医学、放射医学及辐射防护专家的反复论证。但《共识》仍存在很多不足,望刊出后能得到有益的反馈与指正,以便日后进一步完善。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation: UNSCEAR 2000 Report, Annex B (Exposures from natural radiation sources), Annex C (Exposures to the public from man-made sources of radiation)[R]. New York:UNSCEAR, 2000.
返回引文位置Google Scholar
百度学术
万方数据
[2]
潘自强刘森林中国辐射水平[M]北京原子能出版社 2010:1540.
Pan ZQ , Liu SL . Radiation levels in China[M]. Beijing:Atomic Energy Press, 2010:1540.
[3]
《核与辐射安全》编写委员会核与辐射安全[M]北京中国环境出版社 2015:395396.
Writing Committee of Nuclear and Radiation Safety. Nuclear and radiation safety[M]. Beijing:China Environmental Press, 2015:395396.
[4]
中华人民共和国国家质量监督检验检疫总局. GB 18871-2002电离辐射防护与辐射源安全基本标准[S]北京中国标准出版社 2002.
General Administration of Quality Supervision,Inspection and Quarantine of the People′s Republic of China. GB 18871-2002 Basic standards for protection against ionizing radiation and for the safety of radiation sources[S]. Beijing:Standards Press of China, 2002.
[5]
中华人民共和国卫生部. GBZ 120-2006临床核医学放射卫生防护标准[S]北京中国标准出版社 2006.
Chinese Ministry of Health. GBZ 120-2006 Radiological protection standards for clinical nuclear medicine[S]. Beijing:Standards Press of China, 2006.
[6]
International Commission on Radiological Protection. Release of patients after therapy with unsealed radionuclides: ICRP Publication 94[R]. Stockholm:ICRP, 2004.
返回引文位置Google Scholar
百度学术
万方数据
[7]
International Atomic Energy Agency. Applying radiation safety standards in nuclear medicine: safety reports series No.40[R]. Vienna:IAEA, 2005.
返回引文位置Google Scholar
百度学术
万方数据
[8]
中华人民共和国卫生部. GBZ 133-2009医用放射性废物的卫生防护管理[S]北京中国标准出版社 2009.
Chinese Ministry of Health. GBZ 133-2009 Radiological protection management for medical radioactive waste[S]. Beijing:Standards Press of China, 2009.
[9]
中华人民共和国国家卫生和计划生育委员会. WS 457-2014医学与生物学实验室使用非密封放射性物质的放射卫生防护基本要求[S]北京中国标准出版社 2014.
National Health and Family Planning Commission of the People′s Republic of China. WS 457-2014 Basic requirements of radiological protection for using unsealed radioactive material in medical and biological laboratory[S]. Beijing:Standards Press of China, 2014.
[10]
中华人民共和国国家卫生和计划生育委员会. GBZ 178-2014低能γ射线粒籽源植入治疗放射防护要求与质量控制检测规范[S]北京中国标准出版社 2014.
National Health and Family Planning Commission of the People′s Republic of China. GBZ 178-2014 Specifications for radiological protection and quality control in implanted treatment of low energy γ-ray seed sources[S]. Beijing:Standards Press of China, 2014.
[11]
中华人民共和国卫生部中国国家标准化管理委员会. GB 16361-2012临床核医学的患者防护与质量控制规范[S]北京中国标准出版社 2012.
Chinese Ministry of Health,Standardization Administration of China. GB 16361-2012 Specification for patients radiological protection and quality control in nuclear medicine[S]. Beijing:Standards Press of China, 2012.
[12]
American Thyroid Association Taskforce On Radioiodine Safety, Sisson JC , Freitas J ,et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association [J]. Thyroid, 2011,21(4):335346. DOI: 10.1089/thy.2010.0403 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Sawka AM , Lakra DC , Lea J ,et al. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors[J]. Clin Endocrinol (Oxf), 2008,69(3):479490. DOI: 10.1111/j.1365-2265.2008.03222.x .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Sawka AM , Lea J , Alshehri B ,et al. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors[J]. Clin Endocrinol (Oxf), 2008,68(4):610617. DOI: 10.1111/j.1365-2265.2007.03081.x .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Leide-Svegborn S , Ahlgren L , Johansson L ,et al. Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption[J]. Eur J Nucl Med Mol Imaging, 2016,43(5):808821. DOI: 10.1007/s00259-015-3286-0 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
International Atomic Energy Agency. Release of patients after radionuclide therapy: safety reports series No.63[R]. Vienna:IAEA, 2009.
返回引文位置Google Scholar
百度学术
万方数据
[17]
王任飞谭建张桂芝分化型甲状腺癌患者 131I治疗后外部剂量当量率与体内放射性活度残留量的相关性 [J]中华核医学与分子影像杂志 2016,36(5):394397. DOI: 10.3760/cma.j.issn.2095-2848.2016.05.004 .
返回引文位置Google Scholar
百度学术
万方数据
Wang RF , Tan J , Zhang GZ ,et al. Correlation between external dose equivalent rate and residual radioactivity in patients with differentiated thyroid carcinoma after 131I therapy [J]. Chin J Nucl Med Mol Imaging, 2016,36(5):394397. DOI: 10.3760/cma.j.issn.2095-2848.2016.05.004 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[18]
汤敏敏刘建中武志芳分化型甲状腺癌患者 131I治疗后体内残留放射性活度的评估 [J]中华放射医学与防护杂志 2015,35(4):299302. DOI: 10.3760/cma.j.issn.0254-5098.2015.04.016 .
返回引文位置Google Scholar
百度学术
万方数据
Tang MM , Liu JZ , Wu ZF ,et al. Estimation of residual activity in patients with differentiated thyroid cancer after administration of 131I for therapy [J]. Chin J Radiol Med Prot, 2015,35(4):299302. DOI: 10.3760/cma.j.issn.0254-5098.2015.04.016 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[19]
陆克义段炼李险峰. 131I治疗甲状腺疾病后对周围人群的辐射安全性评价 [J]中华放射医学与防护杂志 2007,27(2):184187. DOI: 10.3760/cma.j.issn.0254-5098.2007.02.026 .
返回引文位置Google Scholar
百度学术
万方数据
Lu KY , Duan L , Li XF ,et al. Radiation safety evaluation of 131I after treatment of patients with thyroid diseases for surrounding people [J]. Chin J Radiol Med Prot, 2007,27(2):184187. DOI: 10.3760/cma.j.issn.0254-5098.2007.02.026 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
备注信息
A
李亚明,Email: mocdef.3ab611002ilmy;李思进,Email: mocdef.3ab61321mnjsil
B

本文直接使用的缩略语:DTPA(diethylene triamine pentoacetic acid),二乙撑三胺五乙酸;FDG(fluorodeoxyglucose),脱氧葡萄糖;MAA(macroaggregated albumin),聚合白蛋白;MDP(methylene diphosphonate),亚甲基二膦酸盐;MIBI(methoxyisobutylisonitrile),甲氧基异丁基异腈

C
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号